After Hours Summary: EXPO +12%, CSX -4%, UAL / IBM -3% following earnings/guidance, SNI +15% and DISCA +8% on potential deal talksAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: EXPO +11.8%, WTFC +1.5%
Companies trading higher in after hours in reaction to news: AEZS +45.1% (FDA granted NDA for Macrilen for the evaluation of growth hormone deficiency in adults December 30, 2017 PDUFA date), VRTX +25.2% (announces 'positive' Phase 1 & Phase 2 data from three different triple combination regimens in people with cystic fibrosis who have one F508del mutation and one minimal function mutation), PED +21.6% (provided transaction update; asset due diligence completed, successfully definitive documents now being drafted and anticipates closing by August 31, 2017), SNI +14.7% and DISCA +7.9% (WSJ reporting that Discovery Communications and Scripps are exploring M&A deal), OPGN +12.6% (CFO and CEO disclose purchases likely made under July 13 offering priced at $0.40/share), JONE +3.6% (reports Q2 production exceeding high end of guidance; schedules call to discuss mid-year updates tomorrow), WKHS +2.2% (after seeing notable move higher Tuesday afternoon), ANF +1.5% (SLS Management sends letter to the Board outlining actionable steps for it to undertake to maximize value for the shareholders), CELG +0.5% and AMGN +0.4% (still checking may be attributed to VRTX news)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CSX -3.9%, UAL -3.4%, IBM -2.7%, IBKR -1.1%
Companies trading lower in after hours in reaction to news: DRYS -28% (to effect a 1-for-7 reverse stock split of the Company's issued common shares), OHGI -11.4% (discloses entry into securities purchase agreement with two investors), INO -8.3% (to offer $75.0 mln of shares of its common stock in an underwritten public offering), HDP -8% (announces Pres/COO departure and other mgmt changes; expects Q2 total GAAP revs of $58-59 mln vs $57.2 mln consensus), MMYT -4.6% (ticking lower; files for 15,357,028 ordinary share offering by shareholders), SPEX -4.5% (after filing another amended S-1 with offering of approx 1.18 mln shares of common stock), GLPG -3.2% (ticking lower; attributed to VRTX news), UNP -0.9% (CSX sympathy), WY -0.5% (ticking lower; is implementing solution to address TJI Joists with Flak Jacket Protection product concerns; expecting before-tax costs of $50-60 mln)
United Continental (UAL) earnings/guidance weighing on airline names: SAVE -2.9%, AAL -1.5%, DAL -1.3% (ALSO VP/Chief Acctg Officer sold 5K shares), LUV -0.9%, JBLU -0.7%, ALK -0.5%
![]()
Closing Market Summary: Nasdaq Advances to New All-Time HighFor the first time since June 8, the tech-heavy Nasdaq (+0.5%) advanced to a new record high on Tuesday as tech stocks continued their bullish run. The S&P 500 (+0.1%) also finished at a new record high while the Dow and the small-cap Russell 2000 underperformed, dropping 0.3% apiece. The three major averages settled the session at their best marks of the day.
Only five of the S&P 500's eleven sectors settled in positive territory, but, luckily for the broader market, one of those groups was the top-weighted technology space (+0.5%). Mega-cap names like Facebook (FB 162.86, +3.13) and Alphabet (GOOGL 986.95, +10.99) paced the sector's advance, adding 2.0% and 1.1%, respectively, with FB notching a new all-time high.
Today's win marks the eighth in a row for the technology sector, which has fully recovered from last month's swoon. For the year, the tech space trades comfortably ahead of its peers with a year-to-date gain of 22.1%. For comparison, the S&P 500 holds a year-to-date gain of 9.9% and the health care sector, which hovers in second place on the 2017 leaderboard, is up 15.9% on the year.
Meanwhile, the consumer discretionary sector (+0.4%) also put together a relatively solid performance, leaning on Amazon (AMZN 1024.38, +14.34) to overcome losses from most components. AMZN shares advanced 1.4% to a new all-time high. The lightly-weighted utilities group (+0.3%) was the only other sector to settle ahead of the broader market.
The influential health care group (+0.1%) eked out a narrow victory, thanks in part to the solid performances of Johnson & Johnson (JNJ 134.46, +2.31) and UnitedHealth (UNH 186.85, +0.50). The two companies advanced 1.8% and 0.3%, respectively, after reporting better than expected earnings and issuing upbeat guidance.
On a related note, Senate Majority Leader Mitch McConnell decided to pave a new direction for the upper chamber on Monday evening, trimming aspirations to repeal and replace the Affordable Care Act in favor of a straight repeal with no immediate replacement. However, three centrist-Republican Senators publicly opposed the idea on Tuesday, sending Republican leaders back to the drawing board.
Back on Wall Street, earnings played a role in the heavily-weighted financial sector's underperformance as Goldman Sachs (GS 223.31, -5.95) and Bank of America (BAC 23.90, -0.12) beat earnings and revenue estimates, but failed to live up to the bullish five-week run that financials enjoyed ahead of earnings season. The financial sector ended the day lower by 0.3%.
Like financials, the energy sector (-0.5%) also had a rough showing, despite a positive performance from crude oil, which climbed 0.8% to $46.40/bbl. The commodity benefited from reports that Saudi Arabia is considering a reduction in its crude exports, in addition to a weakening U.S. Dollar; the U.S. Dollar Index (94.42, -0.50) dropped 0.5% to settle at an 11-month low.
As for the remaining laggards, the telecom services group (-1.0%) was the weakest performer while the industrials (-0.3%), materials (-0.4%), and real estate (-0.1%) spaces settled with more moderate losses.
Reviewing Tuesday's economic data, which included June Export/Import Prices and the July NAHB Housing Market Index:
- Import prices excluding oil rose 0.1% in June after finishing flat in May. Export prices excluding agriculture were unchanged in June (0.0%) after declining 0.4% in May (from -0.6%).
- The key takeaway from the report is that it doesn't change the market's understanding -- or the Fed's -- that inflation readings remain low.
- The NAHB Housing Market Index for July declined to 64 (consensus 67) from a revised reading of 66 in June (from 67).
On Wednesday, investors will receive the weekly MBA Mortgage Applications Index and June Housing Starts (consensus 1160K) at 7:00 ET and 8:30 ET, respectively.
- Nasdaq Composite +17.9% YTD
- S&P 500 +9.9% YTD
- Dow Jones Industrial Average +9.2% YTD
- Russell 2000 +5.2% YTD
![]()
- Reports Q2 (Jun) earnings of $2.97 per share, excluding non-recurring items, $0.23 better than the Capital IQ Consensus of $2.74; revenues fell 4.7% year/year to $19.29 bln vs the $19.45 bln Capital IQ Consensus.
-
Segment Results for Second Quarter
- Cognitive Solutions (includes solutions software and transaction processing software)- revenues of $4.6 billion, down 2.5 percent (down 1.4 percent adjusting for currency).
- Global Business Services (includes consulting, global process services and application management)- revenues of $4.1 billion, down 3.7 percent (down 1.7 percent adjusting for currency). Strategic imperatives grew 8 percent led by the cloud and mobile practices.
- Technology Services & Cloud Platforms (includes infrastructure services, technical support services and integration software)- revenues of $8.4 billion, down 5.1 percent (down 3.6 percent adjusting for currency). Strategic imperatives, driven by hybrid cloud services, grew 20 percent.
- Systems (includes systems hardware and operating systems software)- revenues of $1.7 billion, down 10.4 percent (down 9.6 percent adjusting for currency).
- Global Financing (includes financing and used equipment sales)- revenues of $415 million, down 2.2 percent (down 1.7 percent adjusting for currency).
- Co reaffirms guidance for FY17, sees EPS of 'at least' $13.80, excluding non-recurring items, vs. $13.68 Capital IQ Consensus Estimate.
- We welcome Abercrombie's commitment to shareholder returns; however, there is a time in every company's life for buybacks and a time for dividends. With the stock trading at current valuations and a margin of safety from the value of non-core assets, this is the time for buybacks. We highly recommend a change to Abercrombie's capital allocation strategy that will drive a significant increase in shareholder value. We are outlining two options. Option A is a large one-time buyback in conjunction with a reduction in your dividend. Option B is a monetization of assets comprising a substantial portion of Abercrombie's current valuation that Wall Street analysts and investors are giving you no credit for.
- Regardless of which of the above options the Board decides to pursue, we believe the Company should work to unwind the overfunded Rabbi Trust, which sits in Other Assets on the balance sheet and is a legacy of the Jefferies era. Based on our conversations with management, the trust is $25-40M overfunded and could be unwound, providing an additional source of liquidity for the company. Let's hypothetically illustrate how significant the opportunities on balance sheet are. If you were to execute Option A, Option B and liquidate the Rabbi Trust, the Company could buy back roughly 65% of its shares and save $37M per year ($12M cost of Option A and B and $49M savings from dividend reduction). We have proposed two actionable plans. Either of these two options should be enacted immediately. If you are right and the back half of the year is a turning point, a significant value enhancing opportunity will disappear.